Locke Richard, Comfort Rachael, Kubba Haytham
Department of Paediatric Otolaryngology, Royal Hospital for Sick Children, Yorkhill, Glasgow G3 8SJ, Scotland, United Kingdom.
Department of Paediatric Otolaryngology, Royal Hospital for Sick Children, Yorkhill, Glasgow G3 8SJ, Scotland, United Kingdom.
Int J Pediatr Otorhinolaryngol. 2014 Mar;78(3):393-401. doi: 10.1016/j.ijporl.2013.12.011. Epub 2013 Dec 18.
Palpable cervical lymphadenopathy is very common in children. The clinician's job is to exclude malignancy as a cause and reach a diagnosis. In children selected for open biopsy, reactive hyperplasia and other inflammatory causes are far more common as a final diagnosis than malignancy. Furthermore complications can occur after open biopsy.
To assess the diagnostic utility of clinical examination and investigations to exclude malignancy and other serious causes of paediatric cervical lymphadenopathy and minimise open biopsy.
A systematic review of the literature with defined search strategy.
A structured search of Medline, Embase, CINAHL and Cochrane databases. The references within standard paediatric ENT and head and neck textbooks were also examined.
The quality of evidence regarding predictors of malignancy is poor. Large lymph nodes and supraclavicular nodes are potential indicators of serious pathology. Fever, weight loss and organomegaly may be indicators but duration of symptoms and consistency are not. Abnormalities on chest X-ray are associated with serious causes but the diagnostic utility of routine chest X-ray is unknown. Ultrasound assessment of nodal architecture, margins, and shape (and possibly vascularity) shows considerable promise as a means of differentiating reactive hyperplasia from malignancy but further studies in children are required. Abnormalities in the full blood count (FBC) seem to be uncommon but when present are associated with serious causes of cervical lymphadenopathy, again the diagnostic utility is unclear. Serological testing may identify a specific cause and therefore avoid excision biopsy in around 10% of cases. Cutting needle biopsy requires further evaluation before it can be recommended. Fine needle aspiration cytology (FNAC) is very specific, but sensitivity varies in different studies to the extent that it cannot yet be relied upon to exclude malignancy.
Large and supraclavicular nodes should be biopsied. Ultrasound is likely to be useful but further study is required. FNAC cannot be relied upon to exclude malignancy in children. The diagnostic utility of chest X-ray and FBC are unclear. Work is required on multivariate predictive models.
可触及的颈部淋巴结病在儿童中非常常见。临床医生的工作是排除恶性肿瘤作为病因并做出诊断。在选择进行开放性活检的儿童中,反应性增生和其他炎症性病因作为最终诊断远比恶性肿瘤常见。此外,开放性活检后可能会出现并发症。
评估临床检查和检查手段在排除儿童颈部淋巴结病的恶性肿瘤及其他严重病因方面的诊断效用,并尽量减少开放性活检。
采用明确检索策略对文献进行系统综述。
对医学索引数据库(Medline)、荷兰医学文摘数据库(Embase)、护理学与健康领域数据库(CINAHL)和考科蓝图书馆数据库进行结构化检索。还查阅了标准儿科耳鼻喉科及头颈教科书内的参考文献。
关于恶性肿瘤预测指标的证据质量较差。大的淋巴结和锁骨上淋巴结是严重病变的潜在指标。发热、体重减轻和器官肿大可能是指标,但症状持续时间和质地不是。胸部X线异常与严重病因相关,但常规胸部X线的诊断效用尚不清楚。超声对淋巴结结构、边缘和形状(可能还有血管情况)的评估作为区分反应性增生与恶性肿瘤的手段显示出很大前景,但需要在儿童中进一步研究。全血细胞计数(FBC)异常似乎不常见,但出现时与颈部淋巴结病的严重病因相关,同样诊断效用尚不清楚。血清学检测可能识别出特定病因,因此在约10%的病例中可避免切除活检。切割针活检在能够推荐之前需要进一步评估。细针穿刺细胞学检查(FNAC)非常特异,但在不同研究中敏感性差异很大,以至于尚不能依靠它来排除恶性肿瘤。
应活检大的和锁骨上淋巴结。超声可能有用,但需要进一步研究。不能依靠FNAC排除儿童恶性肿瘤。胸部X线和FBC的诊断效用尚不清楚。需要开展多变量预测模型的研究。